Evidence map›Paper›PMID 29415878›Full record

ArticleJCI insight2018

Chronic cigarette smoke exposure induces systemic hypoxia that drives intestinal dysfunction.

Michael Fricker, Bridie J Goggins, Sean Mateer, Bernadette Jones, Richard Y Kim, Shaan L Gellatly, Andrew G Jarnicki, Nicholas Powell, Brian G Oliver, Graham Radford-Smith and 4 more

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 88 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
88citing papers in PubMed, 4 pooled it
13.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

88 citing papers in PubMed, 4 syntheses or guidelines pooled it, 166 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Review
  11. Article
  12. The gut as a central hub for multi-organ crosstalk in aging.Cellular and molecular life sciences : CMLS · 2026
    Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article

28 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 2 countries.

Michael FrickerPriority research Centre for Healthy Lungs, University of Newcastle and.
Bridie J GogginsHunter Medical Research Institute, Newcastle, New South Wales, Australia.
Sean MateerHunter Medical Research Institute, Newcastle, New South Wales, Australia.
Bernadette JonesPriority research Centre for Healthy Lungs, University of Newcastle and.
Richard Y KimPriority research Centre for Healthy Lungs, University of Newcastle and.
Shaan L GellatlyPriority research Centre for Healthy Lungs, University of Newcastle and.
Andrew G JarnickiPriority research Centre for Healthy Lungs, University of Newcastle and.
Nicholas PowellFaculty of Translational Medicine, Guy's and St. Thomas' and King's College London Comprehensive Biomedical Research Centre, Great Maze Pond, London, United Kingdom.
Brian G OliverWoolcock Institute of Medical Research, The University of Sydney, Sydney, New South Wales, Australia.
Graham Radford-SmithRoyal Brisbane and Women's Hospital, Brisbane, School of Medicine, University of Queensland, and.
Nicholas J TalleyPriority Research Centre for Digestive Health and Neurogastroenterology, University of Newcastle, New South Wales, Australia.
Marjorie M WalkerPriority Research Centre for Digestive Health and Neurogastroenterology, University of Newcastle, New South Wales, Australia.
Simon KeelyHunter Medical Research Institute, Newcastle, New South Wales, Australia.
Philip M HansbroPriority research Centre for Healthy Lungs, University of Newcastle and.
Hunter Medical Research Institute · AUUniversity of Newcastle Australia · AUKing's College London · GBThe University of Queensland · AUUniversity of Technology Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Crohn's disease (CD) is a chronic inflammatory disease of the gastrointestinal tract (GIT). Cigarette smoke (CS) exposure and chronic obstructive pulmonary disease (COPD) are risk factors for CD, although the mechanisms involved are poorly understood. We employed a mouse model of CS-induced experimental COPD and clinical studies to examine these mechanisms. Concurrent with the development of pulmonary pathology and impaired gas exchange, CS-exposed mice developed CD-associated pathology in the colon and ileum, including gut mucosal tissue hypoxia, HIF-2 stabilization, inflammation, increased microvasculature, epithelial cell turnover, and decreased intestinal barrier function. Subsequent smoking cessation reduced GIT pathology, particularly in the ileum. Dimethyloxaloylglycine, a pan-prolyl hydroxylase inhibitor, ameliorated CS-induced GIT pathology independently of pulmonary pathology. Prior smoke exposure exacerbated intestinal pathology in 2,4,6-trinitrobenzenesulfonic acid-induced (TNBS-induced) colitis. Circulating vascular endothelial growth factor, a marker of systemic hypoxia, correlated with CS exposure and CD in mice and humans. Increased mucosal vascularisation was evident in ileum biopsies from CD patients who smoke compared with nonsmokers, supporting our preclinical data. We provide strong evidence that chronic CS exposure and, for the first time to our knowledge, associated impaired gas exchange cause systemic and intestinal ischemia, driving angiogenesis and GIT epithelial barrier dysfunction, resulting in increased risk and severity of CD.

Indexed as

AdultAgedAmino Acids, DicarboxylicAnimalsBiopsyCell HypoxiaColonColonoscopyCrohn DiseaseDisease Models, AnimalDisease ProgressionFemaleHumansIleumIntestinal MucosaLungAmino Acids, DicarboxylicoxalylglycineProlyl-Hydroxylase InhibitorsProlyl HydroxylasesSmokeTrinitrobenzenesulfonic AcidCOPDGastroenterologyhypoxiaInflammatory bowel diseasePulmonology

Identifiers

PMID29415878
PMCPMC5821186
OpenAlexW2787440058

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.